News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zhongsheng Pharma Commits $3 Million to Three Novel Drugs


9/26/2011 2:35:52 PM

September 26, 2011 -- Guangdong Zhongsheng Pharma will spend 20 million RMB ($3.1 million) to develop three new drugs to treat pulmonary fibrosis, diabetes and solid-tumor cancers in cooperation with Sichuan University and Guangdong South China Center for Innovative Pharmaceuticals. Zhongsheng Pharma owns the IP for the drugs, which have completed their pre-clinical development. More details....

Stock Symbol: (SHE: 002317)


Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES